Beyond The Numbers: 25 Analysts Discuss Eli Lilly Stock
Portfolio Pulse from Benzinga Insights
Analysts' ratings for Eli Lilly (NYSE:LLY) over the last quarter show a range of sentiments from bullish to bearish. The average 12-month price target has increased by 5.3% to $955.64. Key analysts have raised their price targets, reflecting positive expectations for the company's performance.
August 12, 2024 | 12:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts' ratings for Eli Lilly (NYSE:LLY) over the last quarter show a range of sentiments from bullish to bearish. The average 12-month price target has increased by 5.3% to $955.64. Key analysts have raised their price targets, reflecting positive expectations for the company's performance.
The increase in the average 12-month price target by 5.3% and the positive adjustments by key analysts suggest a bullish sentiment towards Eli Lilly's stock. This is likely to have a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100